HIGH-DOSE 5-FLUOROURACIL (5-FU) AND FOLINIC ACID IN ADVANCED COLORECTAL SITES OF DISEASE CANCER RESISTANT TO STANDARD-DOSE LOCAL 5-FU TREATMENT - RESULTS OF A LIVER PHASE-II STUDY

被引:14
|
作者
JAGER, E [1 ]
KLEIN, O [1 ]
WACHTER, B [1 ]
MULLER, B [1 ]
BRAUN, U [1 ]
KNUTH, A [1 ]
机构
[1] KRANKENHAUS NW FRANKFURT,MED KLIN 2,D-60488 FRANKFURT,GERMANY
关键词
D O I
10.1016/0959-8049(95)00238-E
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1717 / 1717
页数:1
相关论文
共 50 条
  • [1] PHASE-II STUDY OF 5-FLUOROURACIL (5-FU) AND HIGH-DOSE FOLINIC ACID (HDFA) IN HEPATOCELLULAR-CARCINOMA
    ZANIBONI, A
    SIMONCINI, E
    MARPICATI, P
    MARINI, G
    BRITISH JOURNAL OF CANCER, 1988, 57 (03) : 319 - 319
  • [2] SEQUENTIAL METHOTREXATE, 5-FLUOROURACIL (5-FU), AND HIGH-DOSE LEUCOVORIN VERSUS 5-FU AND HIGH-DOSE LEUCOVORIN VERSUS 5-FU ALONE FOR ADVANCED COLORECTAL-CANCER - A MULTIINSTITUTIONAL RANDOMIZED TRIAL
    ABAD, A
    GARCIA, P
    GRAVALOS, C
    TUSQUETS, I
    FONT, A
    PEREZ, G
    CORTESFUNES, H
    FABREGAT, X
    BARNADAS, A
    ROSELL, R
    CANCER, 1995, 75 (06) : 1238 - 1244
  • [3] Phase II study of irinotecan and high dose infusional 5-fluorouracil (5-FU) and folinic acid for first and second line treatment of advanced colorectal cancer.
    Leonard, P
    Ledermann, J
    James, R
    Hochhauser, D
    Seymour, M
    ANNALS OF ONCOLOGY, 2000, 11 : 44 - 45
  • [4] Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid
    Joulia, JM
    Pinguet, F
    Ychou, M
    Duffour, J
    Astre, C
    Bressolle, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (02) : 296 - 301
  • [5] High-dose chronomodulated infusion of 5-fluorouracil (5-FU) and folinic acid (FA) (FF5-16) in advanced colorectal cancer patients
    Terzoli, E
    Garufi, C
    Zappalà, AR
    Vanni, B
    Pugliese, P
    Cappellini, GA
    Aschelter, AM
    Perrone, M
    Giannarelli, D
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (08) : 445 - 452
  • [6] High-dose chronomodulated infusion of 5-fluorouracil (5-FU) and folinic acid (FA) (FF5–16) in advanced colorectal cancer patients
    Edmondo Terzoli
    Carlo Garufi
    Albina Rita Zappalà
    Barbara Vanni
    Patrizia Pugliese
    Giancarlo Antonini Cappellini
    Anna Maria Aschelter
    Maria Perrone
    Diana Giannarelli
    Journal of Cancer Research and Clinical Oncology, 2004, 130 : 445 - 452
  • [7] CLINICAL-EXPERIENCE WITH 5-FLUOROURACIL (5-FU) AND HIGH-DOSE FOLINIC ACID IN SOLID TUMORS
    MARINI, G
    ZANIBONI, A
    GORNI, F
    MARPICATI, P
    MONTINI, E
    SIMONCINI, E
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1987, 13 (06) : 373 - 376
  • [8] WEEKLY REGIMEN OF 5-FU VS 5-FU PLUS INTERMEDIATE DOSE FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER
    MARTONI, A
    CRICCA, A
    GUARALDI, M
    COVIZZI, M
    FARRIS, A
    PANNUTI, F
    ANTICANCER RESEARCH, 1992, 12 (03) : 607 - 612
  • [9] 5-FLUOROURACIL (5-FU) COMBINED WITH LEUCOVORIN (LV) IN PATIENTS WITH ADVANCED 5-FU RESISTANT COLORECTAL-CANCER
    VANGROENINGEN, CJ
    PETERS, GJ
    PINEDO, HM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 202 - 202
  • [10] ALTERED PHARMACOKINETICS OF HIGH-DOSE 5-FLUOROURACIL (5-FU) WITH ALLOPURINOL (HPP) AND ANALYSIS OF ROUTES OF 5-FU ACTIVATION
    SCHWARTZ, PM
    HYDE, CM
    TUREK, PJ
    CADMAN, E
    HANDSCHUMACHER, RE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 222 - 222